LivaNova PLC - LIVN
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 01, 2026 | Chief Executive Officer | A | A | 17,409.0 | 0.0 | 0.0 | 17,409.0 | View | |
| Apr 01, 2026 | Chief Executive Officer | A | A | 17,409.0 | 0.0 | 0.0 | 17,409.0 | View | |
| Apr 01, 2026 | Chief Executive Officer | A | A | 17,409.0 | 0.0 | 0.0 | 17,409.0 | View | |
| Apr 01, 2026 | Chief Executive Officer | A | A | 52,227.0 | 0.0 | 0.0 | 52,227.0 | View | |
| Apr 01, 2026 | Chief Executive Officer | M | D | 11,713.0 | 0.0 | 0.0 | 23,426.0 | View | |
| Apr 01, 2026 | Chief Executive Officer | M | D | 5,977.0 | 0.0 | 0.0 | 11,954.0 | View | |
| Apr 01, 2026 | Chief Executive Officer | M | D | 3,352.0 | 0.0 | 0.0 | 6,703.0 | View | |
| Apr 01, 2026 | Chief Executive Officer | F | D | 11,159.0 | 61.27 | 683,711.93 | 14,167.0 | View | |
| Apr 01, 2026 | Chief Executive Officer | M | A | 21,042.0 | 0.0 | 0.0 | 25,326.0 | View | |
| Apr 01, 2026 | Chief Financial Officer | A | A | 5,440.0 | 0.0 | 0.0 | 5,440.0 | View | |
| Apr 01, 2026 | Chief Financial Officer | A | A | 5,440.0 | 0.0 | 0.0 | 5,440.0 | View | |
| Apr 01, 2026 | Chief Financial Officer | A | A | 5,440.0 | 0.0 | 0.0 | 5,440.0 | View | |
| Apr 01, 2026 | Chief Financial Officer | A | A | 16,321.0 | 0.0 | 0.0 | 16,321.0 | View | |
| Apr 01, 2026 | Chief Financial Officer | M | D | 10,769.0 | 0.0 | 0.0 | 0.0 | View | |
| Apr 01, 2026 | Chief Financial Officer | M | D | 5,612.0 | 0.0 | 0.0 | 0.0 | View | |
| Apr 01, 2026 | Chief Financial Officer | M | D | 5,768.0 | 0.0 | 0.0 | 0.0 | View | |
| Apr 01, 2026 | Chief Financial Officer | M | D | 3,621.0 | 0.0 | 0.0 | 7,240.0 | View | |
| Apr 01, 2026 | Chief Financial Officer | M | D | 1,787.0 | 0.0 | 0.0 | 3,575.0 | View | |
| Apr 01, 2026 | Chief Financial Officer | M | D | 2,364.0 | 0.0 | 0.0 | 2,364.0 | View | |
| Apr 01, 2026 | Chief Financial Officer | M | D | 914.0 | 0.0 | 0.0 | 0.0 | View | |
| Apr 01, 2026 | Chief Financial Officer | F | D | 12,868.0 | 61.27 | 788,422.36 | 44,647.0 | View | |
| Apr 01, 2026 | Chief Financial Officer | M | A | 30,835.0 | 0.0 | 0.0 | 57,515.0 | View | |
| Apr 01, 2026 | President, Cardiopulmonary | M | D | 2,130.0 | 0.0 | 0.0 | 4,258.0 | View | |
| Apr 01, 2026 | President, Cardiopulmonary | M | D | 558.0 | 0.0 | 0.0 | 1,117.0 | View | |
| Apr 01, 2026 | President, Cardiopulmonary | M | D | 325.0 | 0.0 | 0.0 | 325.0 | View | |
| Apr 01, 2026 | President, Cardiopulmonary | M | D | 171.0 | 0.0 | 0.0 | 0.0 | View | |
| Apr 01, 2026 | President, Cardiopulmonary | F | D | 1,370.0 | 61.27 | 83,939.9 | 10,755.0 | View | |
| Apr 01, 2026 | President, Cardiopulmonary | M | A | 3,184.0 | 0.0 | 0.0 | 12,125.0 | View | |
| Apr 01, 2026 | Chief Human Resources Officer | A | A | 3,264.0 | 0.0 | 0.0 | 3,264.0 | View | |
| Apr 01, 2026 | Chief Human Resources Officer | A | A | 3,264.0 | 0.0 | 0.0 | 3,264.0 | View | |
| Apr 01, 2026 | Chief Human Resources Officer | A | A | 3,264.0 | 0.0 | 0.0 | 3,264.0 | View | |
| Apr 01, 2026 | Chief Human Resources Officer | A | A | 9,792.0 | 0.0 | 0.0 | 9,792.0 | View | |
| Apr 01, 2026 | Chief Human Resources Officer | M | D | 2,130.0 | 0.0 | 0.0 | 4,258.0 | View | |
| Apr 01, 2026 | Chief Human Resources Officer | M | D | 4,259.0 | 0.0 | 0.0 | 8,518.0 | View | |
| Apr 01, 2026 | Chief Human Resources Officer | F | D | 1,374.0 | 61.27 | 84,184.98 | 5,015.0 | View | |
| Apr 01, 2026 | Chief Human Resources Officer | M | A | 6,389.0 | 0.0 | 0.0 | 6,389.0 | View | |
| Apr 01, 2026 | President, Global Epilepsy | A | A | 2,992.0 | 0.0 | 0.0 | 2,992.0 | View | |
| Apr 01, 2026 | President, Global Epilepsy | A | A | 2,992.0 | 0.0 | 0.0 | 2,992.0 | View | |
| Apr 01, 2026 | President, Global Epilepsy | A | A | 2,992.0 | 0.0 | 0.0 | 2,992.0 | View | |
| Apr 01, 2026 | President, Global Epilepsy | A | A | 8,976.0 | 0.0 | 0.0 | 8,976.0 | View | |
| Apr 01, 2026 | President, Global Epilepsy | M | D | 6,057.0 | 0.0 | 0.0 | 0.0 | View | |
| Apr 01, 2026 | President, Global Epilepsy | M | D | 3,156.0 | 0.0 | 0.0 | 0.0 | View | |
| Apr 01, 2026 | President, Global Epilepsy | M | D | 3,243.0 | 0.0 | 0.0 | 0.0 | View | |
| Apr 01, 2026 | President, Global Epilepsy | M | D | 2,343.0 | 0.0 | 0.0 | 4,684.0 | View | |
| Apr 01, 2026 | President, Global Epilepsy | M | D | 1,229.0 | 0.0 | 0.0 | 2,457.0 | View | |
| Apr 01, 2026 | President, Global Epilepsy | M | D | 1,330.0 | 0.0 | 0.0 | 1,329.0 | View | |
| Apr 01, 2026 | President, Global Epilepsy | M | D | 457.0 | 0.0 | 0.0 | 0.0 | View | |
| Apr 01, 2026 | President, Global Epilepsy | F | D | 8,377.0 | 61.27 | 513,258.79 | 22,189.0 | View | |
| Apr 01, 2026 | President, Global Epilepsy | M | A | 17,815.0 | 0.0 | 0.0 | 30,566.0 | View | |
| Apr 01, 2026 | Chief Innovation Officer | A | A | 4,624.0 | 0.0 | 0.0 | 4,624.0 | View | |
| Apr 01, 2026 | Chief Innovation Officer | A | A | 4,624.0 | 0.0 | 0.0 | 4,624.0 | View | |
| Apr 01, 2026 | Chief Innovation Officer | A | A | 4,624.0 | 0.0 | 0.0 | 4,624.0 | View | |
| Apr 01, 2026 | Chief Innovation Officer | A | A | 13,873.0 | 0.0 | 0.0 | 13,873.0 | View | |
| Apr 01, 2026 | Chief Innovation Officer | M | D | 3,408.0 | 0.0 | 0.0 | 6,814.0 | View | |
| Apr 01, 2026 | Chief Innovation Officer | F | D | 1,186.0 | 61.27 | 72,666.22 | 4,157.0 | View | |
| Apr 01, 2026 | Chief Innovation Officer | M | A | 3,408.0 | 0.0 | 0.0 | 5,343.0 | View | |
| Mar 13, 2026 | President, Cardiopulmonary | M | D | 2,140.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 13, 2026 | President, Cardiopulmonary | F | D | 69.0 | 62.26 | 4,295.94 | 8,941.0 | View | |
| Mar 13, 2026 | President, Cardiopulmonary | F | D | 1,980.0 | 62.26 | 123,274.8 | 9,010.0 | View | |
| Mar 13, 2026 | President, Cardiopulmonary | M | A | 2,140.0 | 57.6 | 123,264.0 | 10,990.0 | View | |
| Dec 17, 2025 | SVP, CLO and Company Secretary | M | D | 2,254.0 | 0.0 | 0.0 | 2,253.0 | View | |
| Dec 17, 2025 | SVP, CLO and Company Secretary | F | D | 1,122.0 | 63.06 | 70,753.32 | 6,798.0 | View | |
| Dec 17, 2025 | SVP, CLO and Company Secretary | M | A | 2,254.0 | 0.0 | 0.0 | 7,920.0 | View | |
| Dec 17, 2025 | — | M | D | 2,355.0 | 0.0 | 0.0 | 0.0 | View | |
| Dec 17, 2025 | — | F | D | 269.0 | 63.06 | 16,963.14 | 2,086.0 | View | |
| Dec 17, 2025 | — | M | A | 2,355.0 | 0.0 | 0.0 | 2,355.0 | View | |
| Dec 17, 2025 | President, Cardiopulmonary | M | D | 967.0 | 0.0 | 0.0 | 0.0 | View | |
| Dec 17, 2025 | President, Cardiopulmonary | F | D | 416.0 | 63.06 | 26,232.96 | 8,850.0 | View | |
| Dec 17, 2025 | President, Cardiopulmonary | M | A | 967.0 | 0.0 | 0.0 | 9,266.0 | View | |
| Nov 19, 2025 | — | S | D | 250.0 | 53.94 | 13,485.0 | 6,232.0 | View |